| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 17,980 | 21,618 | 22,236 | | Cost of Revenue | 1,888 | 2,082 | 2,322 | | | Gross Profit | 16,093 | 19,536 | 19,914 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 86 | 236 | 139 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 16,006 | 19,301 | 19,775 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (73,309) | (34,273) | (1,509) | | Earnings Before Interest And Taxes | 16,006 | 19,301 | 19,577 | | Interest Expense | 1,577 | 3,060 | 3,344 | | Income Before Tax | 14,429 | 16,241 | 16,233 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (58,880) | (18,032) | 14,922 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (58,880) | (18,032) | 14,922 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($58,880) | ($18,032) | $14,922 |
|
0.51% Nasdaq 
Income Statement
